Articles

Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders

M.D. Anderson Cancer Center, Houston, TX
Orsenix, Wilmington, DE
Orsenix, Wilmington, DE
Memorial Sloan Kettering Cancer Center, New York, NY
Weill Cornell Medicine, New York, NY
Vanderbilt University Medical Center, Nashville, TN, USA
M.D. Anderson Cancer Center, Houston, TX
M.D. Anderson Cancer Center, Houston, TX
M.D. Anderson Cancer Center, Houston, TX
M.D. Anderson Cancer Center, Houston, TX
Orsenix, Wilmington, DE
Orsenix, Wilmington, DE
Orsenix, Wilmington, DE
M.D. Anderson Cancer Center, Houston, TX
Vol. 105 No. 6 (2020): June, 2020 https://doi.org/10.3324/haematol.2019.229583